Robert A. Harrington, M.D.
Board Member
Cytokinetics Inc (CYTK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert A. Harrington, M.D.
Robert A. Harrington, M.D. is recorded as Board Member at Cytokinetics Inc (CYTK). Cytokinetics Inc reported in an 8-K filed May 17, 2024 that Robert A. Harrington, M.D. was appointed Class II Directors, effective May 15, 2024.
“The stockholders elected Robert I. Blum and Robert A. Harrington, M.D. as Class II Directors, each to serve for a three-year term and until their successors are duly elected and qualified or their earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-04-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cytokinetics Inc
Other people whose current roles at this company are on record from its filings.
- Robert Blum CEO
- Robert I. Blum CEO, Board Member
- John T. Henderson, M.D. Chairman
- Sung H. Lee CFO
- Brett Pletcher General Counsel
- Jeffrey J. Hessekiel General Counsel
- Mark A. Schlossberg General Counsel
- Mr. Schlossberg General Counsel
- Mr. Wong Chief Accounting Officer
- Robert Wong Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.